This company listing is no longer active
Taiwan Leader Biotech Balance Sheet Health
Financial Health criteria checks 5/6
Key information
27.2%
Debt to equity ratio
NT$63.63m
Debt
| Interest coverage ratio | n/a |
| Cash | NT$36.75m |
| Equity | NT$234.01m |
| Total liabilities | NT$86.89m |
| Total assets | NT$320.91m |
Recent financial health updates
No updates
Recent updates
Financial Position Analysis
Short Term Liabilities: 8490's short term assets (NT$148.4M) exceed its short term liabilities (NT$26.0M).
Long Term Liabilities: 8490's short term assets (NT$148.4M) exceed its long term liabilities (NT$60.9M).
Debt to Equity History and Analysis
Debt Level: 8490's net debt to equity ratio (11.5%) is considered satisfactory.
Reducing Debt: 8490's debt to equity ratio has increased from 16.2% to 27.2% over the past 5 years.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: 8490 has sufficient cash runway for more than a year based on its current free cash flow.
Forecast Cash Runway: 8490 has sufficient cash runway for 1.5 years if free cash flow continues to grow at historical rates of 26% each year.